Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a
CA 2454822 C · Owner: Petrov, Larry · Inventors: Cliche, Dominic; Carlson, John C.; Petrov, Larry
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to isolated and/or purified rat apoptosisspecific , eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase (DHS) nucleic acids , and polypeptides. The present invention also relates to methods of modulating apoptosis , using apoptosis-specific eIF-5A and DHS and antisense oligonucleotides and , expression vectors of apoptosis-specific eIF-5A and DHS useful in such methods.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 23, 2002 and granted September 23, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 23, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 23, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.